Our findings provide evidence that TOMM40 and APOC1 as candidate genes may promote the application of hippocampal atrophy rate as an early biomarker for predicting cognitive progression and detecting disease trajectories. The gene discussed is TOMM40; the disease is hippocampal atrophy.